Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Washington University School of Medicine
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC